Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats

Human and Experimental Toxicology

Volumn 26, Issue 8, 2007, Pages 637-643

  Núñez, María J ^a   Balboa, José ^a   Rey Méndez, Manuel ^a   Brenlla, Julio ^a   González Peteiro, Mercedes ^a   Rodrigo, Elena ^a   Freire Garabal, Manuel ^a,b  

^a School of Dentistry   (Spain)

^b School of Medicine   (Spain)

Author keywords

Amphetamine; Cocaine; Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis

Indexed keywords

AMPHETAMINE; COCAINE; FREUND ADJUVANT; GAMMA INTERFERON; MYELIN BASIC PROTEIN; PLACEBO;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BRAIN; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATION; DOSE RESPONSE; GUINEA PIG; HISTOLOGY; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; TH1 CELL;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FREUND'S ADJUVANT; GUINEA PIGS; MALE; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; SPINAL CORD; TIME FACTORS;

CAVIA; RATTUS;

EID: 35348866092     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107076323     Document Type: Article

References (34)

1. Hellings N, Baree M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J Neurosci Res 2001; 63: 290-302.
2. Freire-Garabal M, Balboa JL, Núñez MJ, Castaño MT, Llovo JB, Fernández-Rial JC, Belmonte A. Effects of amphetamine on T-cell immune response in mice. Life Sci 1991; 49: 107-12.
3. Núñez MJ, Castro-Bolaño C, Losada C, Pereiro-Raposo MD, Riveiro P, Sánchez-Sebio P, Mayán-Santos JM, Rey-Méndez M, Freire-Garabal M. Effects of amphetamine on cell mediated immune response in mice. Life Sci 1996; 58: 29-33.
4. Di Francesco P, Pica F, Croce C, Favalli C, Tubaro E, Garaci E. Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice. Nat Immun Cell Growth Regul 1990; 9: 397-405.
5. Ou DW, Shen ML, Luo YD. Effects of cocaine on the immune system of BALB/c mice. Clin Immunol Immunopathol 1989; 52: 305-12.
6. Gan X-H, Zhang L, Newton T, Chang SL, Ling W, Kermani V, Berger O, Graves MC, Fiala M. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. Clin Immunol Immunopathol 1998; 89: 181-90.
7. Connor TJ, Kelly JP, Leonard BE. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology 2000; 46: 223-35.
8. Thomas DM, Dowgiert J, Geddes TJ, Francescutti-Verbeem D, Liu X, Kuhn DM. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett 2004; 367: 349-54.
9. Orio L, O'Shea E, Sanchez V, Pradillo JM, Escobedo I, Camarero J, Moro MA, Green AR, Colado MI. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. J Neurochem 2004; 89: 1445-53.
10. Ponomarev ED, Shriver LP, Mars K, Dittel BN. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 2005 81: 374-89.
11. Dousset V, Brochet B, Deloire MS, Lagoarde L, Barroso B, Caille JM, Petry KG. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. Am J Neuroradiol 2006; 27: 1000-05.
12. Johansson BB, Carlsson C. Amphetamine-induced increase of the cerebrovascular permeability to protein. Acta Neurologica Scandinavica 1977; 64: 62-63.
13. Rakic LM, Zlokovic BV, Davson H, Segal MB, Begley DJ, Lipovac MN, Mitrovic DM. Chronic amphetamine intoxication and the blood-brain barrier permeability to inert polar molecules studied in the vascularly perfused guinea pig brain. J Neurol Sci 1989; 94: 41-50.
14. Ahmed Z, Gvereic D, Pryce G, Baker D, Leonard JP, Cuzner ML. Myelin/Axonal pathology in interleukin-12 induced serial relapses of Experimental Allergic Encephalomyelitis in the Lewis rat. Am J Pathol 2001; 158: 2127-38.
15. Stanislaus R, Singh AK, Singh I. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res 2001; 66: 155-62.
16. Bolton C, Paul C. MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J Pharmacol Exp Therap 1997; 282: 397-402.
17. Tanuma N, Shin TS, Matsumoto Y. Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats. J Neuroimmunol 2000; 108: 171-80.
18. MacPhee IAM, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989; 169:431-45.
19. Zenker N, Berstein DE. The stimation of small amounts of corticosterone in rat plasma. J Biol Chem 1958; 231: 695-701.
20. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C. Animal models. Ann Neurol 1994; 36: 47-53.
21. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 1989; 124: 132-43.
22. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol 1990; 8: 579-621.
23. Ruuls SR, Sedgwick JD. Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis. Immunol Cell Biol 1998; 76: 65-73.
24. Becher B, Dodelet V, Fedorowicz V, Antel JP. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest 1996; 98: 1539-43.
25. Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, Van Damme J, Dejana E, Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 549-53.
26. Chung IY, Benveniste EN. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 1990; 144: 2999-3007.
27. ÓBrien NC, Charlton B, Cowden WB, Willenborg DO. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J Immunol 1999; 163: 6841-47.
28. Budziszewska B, Jaworska-Feil L, Lason W. The effect of repeated amphetamine and cocaine administration on adrenal, gonadal and thyroid hormone levels in the rat plasma. Exp Clin Endocrinol Diab 1996; 104: 334-38.
29. Gardner B, Zhu LX, Roth MD, Tashkin DP, Dubinett SM, Sharma S. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol 2004; 147: 95-98.
30. Mao JT, Huang M, Wang J, Sharma S, Tashkin DP, Dubinett SM. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. Cell Immunol 1996; 172: 217-23.
31. Mason D. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunology Today 1991; 12: 57-60.
32. Fiala M, Gan XH, Zhang L, House SD, Newton T, Graves MC, Shapshak P, Stins M, Kim KS, Witte M, Chang SL. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis?. Adv Exp Med Biol 1998; 437: 199-205.
33. Thomas DM, Dowgiert J, Geddes TJ, Francescutti-Verbeem D, Liu X, Kuhn DM. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett 2004; 367: 349-54.
34. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006 [Epub ahead of print].